Cartilage Degeneration Market in North America report 2027 | Size, Share, Growth by Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Cartilage Degeneration Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Cartilage Degeneration Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Aging population
5.1.2 Rising incidence of osteoarthritis

5.2 Market Opportunities

5.2.1 Increased investments in orthopedic research
5.2.2 Growth in healthcare awareness

5.3 Future Trends

5.3.1 Regenerative medicine advancements
5.3.2 Use of 3D printing in treatment

5.4 Impact of Drivers and Restraints

6. North America Cartilage Degeneration Market Regional Analysis

6.1 North America Cartilage Degeneration Market Overview

6.2 North America Cartilage Degeneration Market Revenue 2017-2027 (US$ Million)

6.3 North America Cartilage Degeneration Market Forecast Analysis

7. North America Cartilage Degeneration Market Analysis – by Procedure Type

7.1 Osteochondral Transplant

7.1.1 Overview
7.1.2 Osteochondral Transplant: North America Cartilage Degeneration Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Chondroplasty

7.2.1 Overview
7.2.2 Chondroplasty: North America Cartilage Degeneration Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Joint Replacement

7.3.1 Overview
7.3.2 Joint Replacement: North America Cartilage Degeneration Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Meniscus Transplants

7.4.1 Overview
7.4.2 Meniscus Transplants: North America Cartilage Degeneration Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Cell-based Cartilage Resurfacing

7.5.1 Overview
7.5.2 Cell-based Cartilage Resurfacing: North America Cartilage Degeneration Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Cartilage Degeneration Market Analysis – by Application

8.1 Knee

8.1.1 Overview
8.1.2 Knee: North America Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Hips

8.2.1 Overview
8.2.2 Hips: North America Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)

9. North America Cartilage Degeneration Market Analysis – by End User

9.1 Hospitals & Specialty Clinics

9.1.1 Overview
9.1.2 Hips: North America Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Ambulatory Surgical Centers

9.2.1 Overview
9.2.2 Hips: North America Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)

9.3 Academic & Research Institutes

9.3.1 Overview
9.3.2 Hips: North America Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)

10. North America Cartilage Degeneration Market – North America Analysis

10.1 North America

10.1.1 North America Cartilage Degeneration Market Breakdown, by Key Country, 2020 and 2027 (%)
10.1.1.1 North America Cartilage Degeneration Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 US: North America Cartilage Degeneration Market Breakdown, by Procedure Type
10.1.1.1.2 US: North America Cartilage Degeneration Market Breakdown, by Application
10.1.1.1.3 US: North America Cartilage Degeneration Market Breakdown, by End User

10.1.1.2 Canada: North America Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Canada: North America Cartilage Degeneration Market Breakdown, by Procedure Type
10.1.1.2.2 Canada: North America Cartilage Degeneration Market Breakdown, by Application
10.1.1.2.3 Canada: North America Cartilage Degeneration Market Breakdown, by End User

10.1.1.3 Mexico : North America Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 Mexico : North America Cartilage Degeneration Market Breakdown, by Procedure Type
10.1.1.3.2 Mexico : North America Cartilage Degeneration Market Breakdown, by Application
10.1.1.3.3 Mexico : North America Cartilage Degeneration Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Cartilage Degeneration Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Zimmer Biomet

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Stryker Corporation

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Johnson and Johnson Services, Inc.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 CONMED Corporation

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Arthrex, Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Anika Therapeutics, Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights